-
Something wrong with this record ?
Continued circulation of mpox: an epidemiological and phylogenetic assessment, European Region, 2023 to 2024
AM. Vaughan, M. Afzal, P. Nannapaneni, M. Leroy, X. Andrianou, J. Pires, S. Funke, C. Roman, J. Reyes-Uruena, S. Aberle, A. Aristodimou, G. Aspelund, KF. Bennet, A. Bormane, A. Caraglia, H. Charles, E. Chazelle, I. Christova, O. Cohen, C....
Language English Country Sweden
Document type Journal Article
Grant support
001
World Health Organization - International
NLK
Directory of Open Access Journals
from 1996
Free Medical Journals
from 1995
Freely Accessible Science Journals
from 1995-09-01
PubMed Central
from 2016
Europe PubMed Central
from 2016
Open Access Digital Library
from 1996-01-01
Open Access Digital Library
from 2016-01-01
Medline Complete (EBSCOhost)
from 2010-07-01
ROAD: Directory of Open Access Scholarly Resources
from 1995
- MeSH
- Child MeSH
- Adult MeSH
- Disease Outbreaks * MeSH
- Phylogeny * MeSH
- Incidence MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Child, Preschool MeSH
- Aged MeSH
- Population Surveillance MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Child, Preschool MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Europe MeSH
During the summer of 2023, the European Region experienced a limited resurgence of mpox cases following the substantial outbreak in 2022. This increase was characterised by asynchronous and bimodal increases, with countries experiencing peaks at different times. The demographic profile of cases during the resurgence was largely consistent with those reported previously. All available sequences from the European Region belonged to clade IIb. Sustained efforts are crucial to control and eventually eliminate mpox in the European Region.
Andrija Stampar Teaching Institute of Public Health Zagreb Croatia
Austrian Agency for Health and Food Safety Vienna Austria
Centre for Health Security and Communicable Disease Control Directorate of Health Reykjavik Iceland
Department for Infectious Disease Epidemiology Robert Koch Institute Berlin Germany
Department of Epidemiology and Public Health Sciensano Brussels Belgium
Department of Infectious Diseases Rigshospitalet University Hospital Copenhagen Denmark
Directorate of Information and Analysis Directorate General of Health Lisbon Portugal
Division of Epidemiology Ministry of Health Jerusalem Israel
European Centre for Disease Prevention and Control Stockholm Sweden
Finnish Institute for Health and Welfare Helsinki Finland
HSE Health Protection Surveillance Centre Dublin Ireland
HSE Public Health National Health Protection Office Dublin Ireland
Medical and Public Health Services Nicosia Cyprus
Medical University of Vienna Centre for Virology Vienna Austria
National Center of Infectious and Parasitic Diseases Sofia Bulgaria
National Centre of Epidemiology CIBER in Infectious Diseases Carlos 3 Health Institute Madrid Spain
National Institute of Public Health Bucharest Romania
National Institute of Public Health NIH National Research Institute Warsaw Poland
NIJZ Centre for Communicable Diseases Ljubljana Slovenia
Norwegian Institute of Public Health Oslo Norway
Public Health Agency of Sweden Solna Sweden
Public Health Emergency Centre Directorate General of Health Lisbon Portugal
Santé publique France the French National Public Health Agency Saint Denis France
Santé publique France the French National Public Health Agency Saint Maurice France
School of Health Sciences Ashkelon Academic College Ashkelon Israel
Swiss Federal Office of Public Health Bern Switzerland
These authors contributed equally as first authors
These authors contributed equally as last authors
United Kingdom Health Security Agency London United Kingdom
World Health Organization Regional Office for Europe Copenhagen Denmark
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019855
- 003
- CZ-PrNML
- 005
- 20241024111052.0
- 007
- ta
- 008
- 241015s2024 sw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2807/1560-7917.ES.2024.29.27.2400330 $2 doi
- 035 __
- $a (PubMed)38967012
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Vaughan, Aisling M $u These authors contributed equally as first authors $u World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark
- 245 10
- $a Continued circulation of mpox: an epidemiological and phylogenetic assessment, European Region, 2023 to 2024 / $c AM. Vaughan, M. Afzal, P. Nannapaneni, M. Leroy, X. Andrianou, J. Pires, S. Funke, C. Roman, J. Reyes-Uruena, S. Aberle, A. Aristodimou, G. Aspelund, KF. Bennet, A. Bormane, A. Caraglia, H. Charles, E. Chazelle, I. Christova, O. Cohen, C. Constantinou, S. Couvreur, A. Diaz, K. Fabiánová, F. Ferraro, MP. Grenersen, E. Grilc, T. Hannila-Handelberg, AK. Hvass, D. Igoe, K. Jansen, D. Janță, S. Kaoustou, A. Koch, ML. Kosanovic Licina, S. Krumova, A. Labutin, R. Lachmann, A. Lecompte, R. Lefrançois, V. Leitena, K. Liitsola, I. Mlinarić, Z. Mor, M. Neary, A. Novacek, MW. Øgle, H. Orlíková, K. Papadima, M. Rehn, M. Sadkowska-Todys, A. Sîrbu, K. Sondén, B. Suárez, M. Thordardottir, P. Vasconcelos, J. Vieira Martins, K. Zakrzewska, MA. Widdowson, CM. Gossner
- 520 9_
- $a During the summer of 2023, the European Region experienced a limited resurgence of mpox cases following the substantial outbreak in 2022. This increase was characterised by asynchronous and bimodal increases, with countries experiencing peaks at different times. The demographic profile of cases during the resurgence was largely consistent with those reported previously. All available sequences from the European Region belonged to clade IIb. Sustained efforts are crucial to control and eventually eliminate mpox in the European Region.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a fylogeneze $7 D010802
- 650 12
- $a epidemický výskyt choroby $7 D004196
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a mladý dospělý $7 D055815
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a surveillance populace $7 D011159
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a incidence $7 D015994
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Afzal, Mohammed $u These authors contributed equally as first authors $u European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- 700 1_
- $a Nannapaneni, Priyanka $u European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- 700 1_
- $a Leroy, Mathias $u World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark
- 700 1_
- $a Andrianou, Xanthi $u European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- 700 1_
- $a Pires, Jeffrey $u World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark
- 700 1_
- $a Funke, Silvia $u European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- 700 1_
- $a Roman, Celine $u World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark
- 700 1_
- $a Reyes-Uruena, Juliana $u European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- 700 1_
- $a Aberle, Stephan $u Medical University of Vienna, Centre for Virology, Vienna, Austria
- 700 1_
- $a Aristodimou, Aristos $u Medical and Public Health Services, Nicosia, Cyprus
- 700 1_
- $a Aspelund, Gudrun $u Centre for Health Security and Communicable Disease Control, Directorate of Health, Reykjavik, Iceland
- 700 1_
- $a Bennet, Kirsty F $u United Kingdom Health Security Agency, London, United Kingdom
- 700 1_
- $a Bormane, Antra $u Center for Disease Prevention and Control of Latvia, Department of Infectious Diseases Risk Analysis and Prevention, Riga, Latvia
- 700 1_
- $a Caraglia, Anna $u Ministry of Health, Rome, Italy
- 700 1_
- $a Charles, Hannah $u United Kingdom Health Security Agency, London, United Kingdom
- 700 1_
- $a Chazelle, Emilie $u Santé publique France, the French National Public Health Agency, Saint-Maurice, France
- 700 1_
- $a Christova, Iva $u National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria
- 700 1_
- $a Cohen, Orna $u Division of Epidemiology, Ministry of Health, Jerusalem, Israel
- 700 1_
- $a Constantinou, Costas $u Medical and Public Health Services, Nicosia, Cyprus
- 700 1_
- $a Couvreur, Simon $u Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium
- 700 1_
- $a Diaz, Asuncion $u National Centre of Epidemiology, CIBER in Infectious Diseases (CIBERINFEC), Carlos III Health Institute, Madrid, Spain
- 700 1_
- $a Fabiánová, Kateřina $u National Institute of Public Health, Centre for Epidemiology and Microbiology, Department of Infectious Disease Epidemiology, Prague, Czechia
- 700 1_
- $a Ferraro, Federica $u Ministry of Health, Rome, Italy
- 700 1_
- $a Grenersen, Marte Petrikke $u Norwegian Institute of Public Health (NIPH), Oslo, Norway
- 700 1_
- $a Grilc, Eva $u NIJZ (NIPH), Centre for Communicable Diseases, Ljubljana, Slovenia
- 700 1_
- $a Hannila-Handelberg, Tuula $u Finnish Institute for Health and Welfare, Helsinki, Finland
- 700 1_
- $a Hvass, Anne Kathrine $u Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark
- 700 1_
- $a Igoe, Derval $u HSE Public Health: National Health Protection Office, Dublin, Ireland
- 700 1_
- $a Jansen, Klaus $u Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
- 700 1_
- $a Janță, Denisa $u National Institute of Public Health, Bucharest, Romania
- 700 1_
- $a Kaoustou, Styliani $u Directorate of Epidemiological Surveillance and Intervention for Communicable Diseases, National Public Health Organization, Marousi, Greece
- 700 1_
- $a Koch, Anders $u Department of Infectious Diseases, Rigshospitalet University Hospital, Copenhagen, Denmark $u Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark
- 700 1_
- $a Kosanovic Licina, Mirjana Lana $u Andrija Stampar Teaching Institute of Public Health, Zagreb, Croatia
- 700 1_
- $a Krumova, Stefka $u National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria
- 700 1_
- $a Labutin, Anton $u Swiss Federal Office of Public Health, Bern, Switzerland
- 700 1_
- $a Lachmann, Raskit $u Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
- 700 1_
- $a Lecompte, Amaryl $u Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium
- 700 1_
- $a Lefrançois, Rémi $u Santé publique France, the French National Public Health Agency, Saint-Denis, France
- 700 1_
- $a Leitena, Viktorija $u Center for Disease Prevention and Control of Latvia, Department of Infectious Diseases Risk Analysis and Prevention, Riga, Latvia
- 700 1_
- $a Liitsola, Kirsi $u Finnish Institute for Health and Welfare, Helsinki, Finland
- 700 1_
- $a Mlinarić, Ivan $u Croatian Institute of Public Health, Division for Epidemiology of Communicable Diseases, Zagreb, Croatia
- 700 1_
- $a Mor, Zohar $u School of Health Sciences, Ashkelon Academic College, Ashkelon, Israel $u Division of Epidemiology, Ministry of Health, Jerusalem, Israel
- 700 1_
- $a Neary, Martha $u HSE Health Protection Surveillance Centre, Dublin, Ireland
- 700 1_
- $a Novacek, Alina $u Austrian Agency for Health and Food Safety, Vienna, Austria
- 700 1_
- $a Øgle, Magnus Wenstøp $u Norwegian Institute of Public Health (NIPH), Oslo, Norway
- 700 1_
- $a Orlíková, Hana $u Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Prague, Czechia $u National Institute of Public Health, Centre for Epidemiology and Microbiology, Department of Infectious Disease Epidemiology, Prague, Czechia
- 700 1_
- $a Papadima, Kalliopi $u Directorate of Epidemiological Surveillance and Intervention for Communicable Diseases, National Public Health Organization, Marousi, Greece
- 700 1_
- $a Rehn, Moa $u Public Health Agency of Sweden (PHAS), Solna, Sweden
- 700 1_
- $a Sadkowska-Todys, Malgorzata $u National Institute of Public Health NIH - National Research Institute, Warsaw, Poland
- 700 1_
- $a Sîrbu, Anca $u National Institute of Public Health, Bucharest, Romania
- 700 1_
- $a Sondén, Klara $u Public Health Agency of Sweden (PHAS), Solna, Sweden
- 700 1_
- $a Suárez, Berta $u Coordinating Centre for Health Alerts and Emergencies (CCAES), Directorate General of Public Health, Ministry of Health, Madrid, Spain
- 700 1_
- $a Thordardottir, Marianna $u Centre for Health Security and Communicable Disease Control, Directorate of Health, Reykjavik, Iceland
- 700 1_
- $a Vasconcelos, Paula $u Public Health Emergency Centre, Directorate-General of Health (DGS), Lisbon, Portugal
- 700 1_
- $a Vieira Martins, Joao $u Directorate of Information and Analysis, Directorate-General of Health, Lisbon, Portugal
- 700 1_
- $a Zakrzewska, Karolina $u National Institute of Public Health NIH - National Research Institute, Warsaw, Poland
- 700 1_
- $a Widdowson, Marc-Alain $u These authors contributed equally as last authors $u World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark
- 700 1_
- $a Gossner, Céline M $u These authors contributed equally as last authors $u European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- 773 0_
- $w MED00174364 $t Euro surveillance : bulletin Europeen sur les maladies transmissibles European communicable disease bulletin $x 1560-7917 $g Roč. 29, č. 27 (2024)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38967012 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111046 $b ABA008
- 999 __
- $a ok $b bmc $g 2202207 $s 1231828
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 29 $c 27 $e - $i 1560-7917 $m Euro surveillance : bulletin Europeen sur les maladies transmissibles European communicable disease bulletin $n Euro Surveill $x MED00174364
- GRA __
- $a 001 $p World Health Organization $2 International
- LZP __
- $a Pubmed-20241015
